The global market for Ultrasound Gels was estimated at US$100.6 Million in 2024 and is projected to reach US$113.3 Million by 2030, growing at a CAGR of 2.0% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Ultrasound Gels market.
Global Ultrasound Gel Market - Key Trends & Drivers Summarized
Why Is Ultrasound Gel Essential to Evolving Imaging Protocols in Healthcare?
Ultrasound gel plays a critical role in diagnostic and therapeutic ultrasound procedures by acting as a conductive medium that eliminates air gaps between the transducer and the skin, enabling efficient sound wave transmission. As ultrasound imaging becomes more pervasive across specialties such as obstetrics, cardiology, urology, and emergency medicine, the demand for high-performance ultrasound gels has intensified. The shift toward real-time, bedside, and point-of-care ultrasound (POCUS) is expanding gel usage volumes due to increased frequency and diversity of scans. Portable and handheld ultrasound systems, which are gaining adoption across rural clinics, ambulatory centers, and military field units, also rely on readily deployable gel formats. Specialized applications such as musculoskeletal, intraoperative, and vascular imaging require gels with specific viscosity and conductivity profiles to ensure image clarity and probe sensitivity. Additionally, therapeutic ultrasound procedures for physiotherapy, pain relief, and cosmetic dermatology use large volumes of gel to maintain acoustic coupling and ensure safety over extended treatment durations. As image quality becomes a key differentiator in clinical decision-making, the consistency, purity, and stability of ultrasound gel formulations are receiving heightened scrutiny. These trends are reinforcing the position of ultrasound gel not as a mere accessory, but as a vital consumable supporting precision and reliability in modern medical imaging protocols.How Are Formulation Advances Improving Performance, Safety, and Application Versatility?
Ultrasound gel formulations are undergoing significant enhancements to improve conductivity, patient comfort, and compatibility with a wide range of probes and imaging environments. Modern gels are increasingly being developed with synthetic, water-based polymers that provide consistent viscosity, quick application, and residue-free cleanup. Non-irritating, hypoallergenic, and paraben-free formulations are gaining preference in dermatology, obstetrics, and pediatric use, particularly for patients with sensitive skin. Innovations in bacteriostatic and sterile gel production are addressing infection control priorities, especially in high-risk environments such as ICUs, surgical theaters, and transvaginal or intraoperative ultrasound procedures. Single-use gel sachets and sterile bottles are becoming standard in hospitals adhering to stringent infection prevention protocols. Additionally, non-staining, fragrance-free, and non-greasy formulations are improving user and patient experience during prolonged scanning sessions. Gels with advanced thermal properties are being designed to reduce probe heating and improve patient comfort, especially during therapeutic ultrasound. The use of color-tinted or self-leveling gels is helping technicians visually confirm even coverage across curved or irregular anatomical areas. Manufacturers are also developing environmentally friendly gel products using biodegradable components and recyclable packaging to align with green procurement policies in healthcare institutions. These formulation innovations are enhancing ultrasound gel's utility across diverse clinical, therapeutic, and field-based applications.What Healthcare Delivery and Usage Trends Are Reshaping Market Demand?
Structural changes in healthcare delivery are reshaping how and where ultrasound gel is used, leading to broader and more frequent application across varied care settings. The decentralization of diagnostic imaging - driven by mobile clinics, urgent care facilities, and tele-ultrasound platforms - is increasing point-of-care gel usage in remote and resource-limited environments. Aging populations and the global increase in chronic conditions such as cardiovascular disease, renal failure, and liver cirrhosis are driving ultrasound utilization for regular monitoring, further escalating gel consumption. The rise of outpatient surgeries, prenatal care programs, and community health screening initiatives is also contributing to higher demand for gel across non-hospital settings. In trauma care and emergency departments, where ultrasound is used for rapid internal assessment, the availability of ready-to-use gel formats is crucial for timely intervention. Academic and training institutions are fueling demand for bulk gel formats and long-lasting formulations to support repeated use on practice mannequins and during live scanning sessions. Meanwhile, the aesthetics and physiotherapy markets are expanding gel demand outside of core medical domains through applications such as cellulite reduction, tendonitis treatment, and ultrasound-assisted lipolysis. Additionally, increased hospital procurement standardization and group purchasing contracts are reshaping sourcing dynamics, emphasizing quality consistency, cost efficiency, and packaging innovation. These trends collectively support continuous and expanding demand for ultrasound gel across clinical, therapeutic, and consumer wellness ecosystems.The Growth In The Ultrasound Gel Market Is Driven By Several Factors…
Rising global utilization of ultrasound across diagnostic, interventional, and therapeutic applications is a primary growth driver for the ultrasound gel market. The increasing adoption of point-of-care and portable ultrasound systems is creating consistent demand for easy-to-use, sterile gel formats suitable for high-frequency deployment in varied settings. Expanding ultrasound access in developing regions - enabled by mobile clinics, telemedicine platforms, and government screening programs - is further amplifying volume demand. Regulatory emphasis on infection prevention is driving widespread shift toward single-use and sterile-packaged gel formats, especially in critical care and invasive imaging procedures. Advances in ultrasound technology, including 3D/4D imaging, elastography, and contrast-enhanced scans, require high-conductivity gel to maintain optimal image resolution and probe responsiveness. Growth in therapeutic ultrasound usage - spanning musculoskeletal rehabilitation, chronic pain management, and cosmetic dermatology - is contributing to sustained non-diagnostic gel demand. Additionally, increasing healthcare investments, rising awareness of preventive diagnostics, and training-driven demand in medical education are expanding the market base. Institutional procurement trends favoring eco-friendly, hypoallergenic, and multi-format gel options are supporting product diversification. Collectively, these drivers are reinforcing the ultrasound gel market's role as a critical enabler of high-quality imaging and therapy in a fast-evolving global healthcare landscape.Scope of Study:
The report analyzes the Ultrasound Gels market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Type (Non-Sterile, Sterile); End-Use (Hospitals, Clinics, Diagnostic centers, Ambulatory Surgery Centers)
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Non-Sterile segment, which is expected to reach US$67.2 Million by 2030 with a CAGR of a 1.5%. The Sterile segment is also set to grow at 2.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $27.4 Million in 2024, and China, forecasted to grow at an impressive 3.7% CAGR to reach $21.0 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Ultrasound Gels Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Ultrasound Gels Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Ultrasound Gels Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Aquasonic Gel (Parker Laboratories), Bovie Medical Corporation, Cardinal Health, Compass Health Brands, Eco-Med Diagnostic Imaging and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 41 companies featured in this Ultrasound Gels market report include:
- Aquasonic Gel (Parker Laboratories)
- Bovie Medical Corporation
- Cardinal Health
- Compass Health Brands
- Eco-Med Diagnostic Imaging
- EDM Medical Solutions
- Feta Med Inc
- GE Healthcare
- GIMA S.p.A.
- Graphic Controls
- H.R. Pharmaceuticals, Inc.
- Johnson & Johnson
- Krystal Gels
- Macromedica USA
- Medline Industries, LP
- Medtronic plc
- Metro Surgical
- Miot Medical Supplies Pvt Ltd
- Naimco
- Nissha Medical Technologies
- Parker Laboratories Inc.
- Sonogel Vertriebs GmbH
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aquasonic Gel (Parker Laboratories)
- Bovie Medical Corporation
- Cardinal Health
- Compass Health Brands
- Eco-Med Diagnostic Imaging
- EDM Medical Solutions
- Feta Med Inc
- GE Healthcare
- GIMA S.p.A.
- Graphic Controls
- H.R. Pharmaceuticals, Inc.
- Johnson & Johnson
- Krystal Gels
- Macromedica USA
- Medline Industries, LP
- Medtronic plc
- Metro Surgical
- Miot Medical Supplies Pvt Ltd
- Naimco
- Nissha Medical Technologies
- Parker Laboratories Inc.
- Sonogel Vertriebs GmbH
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 278 |
Published | July 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 100.6 Million |
Forecasted Market Value ( USD | $ 113.3 Million |
Compound Annual Growth Rate | 2.0% |
Regions Covered | Global |